July 14, 2015
Singulex Demonstrates Ultrasensitive “Sgx ClarityTM System” at AACC 2015
May 21, 2015
Singulex Announces EMD Millipore to Acquire Exclusive Rights to Singulex’s Ultra-Sensitive Single Molecule Counting (SMCTM) Technology
Single Molecule Counting (SMC™) from Singulex is transforming clinical diagnostics and scientific discovery.
Singulex is the developer and leading provider of single molecule counting (SMCTM) technology for clinical diagnostics and scientific discovery. Singulex's proprietary SMC technology enables physicians and scientists to detect biomarkers of disease that were previously undetectable. Powered by SMC technology, Singulex's ultra-sensitive immunoassay solutions and lab testing services are transforming patient care from reactive disease treatment to proactive health management and fueling the discovery and development of new therapeutics.